Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies

被引:106
|
作者
Wu, Q. [1 ]
Bencaz, A. F. [2 ]
Hentz, J. G. [1 ]
Crowell, M. D. [1 ]
机构
[1] Mayo Clin, Coll Med, Scottsdale, AZ 85259 USA
[2] Louisiana State Univ, Sch Med, Hlth Sci Ctr, New Orleans, LA USA
关键词
Antidepressant; Bone fractures; Bone mineral density; Depression; Osteoporosis; Serotonin reuptake inhibitors; HIP-FRACTURES; BONE LOSS; ANTIDEPRESSANTS; PUBLICATION; FALLS; BIAS; MEDICATIONS; PEOPLE; TRENDS; RATES;
D O I
10.1007/s00198-011-1778-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A Studies on use of selective serotonin reuptake inhibitors (SSRIs) and risk of fracture have yielded inconsistent results. This meta-analysis, which pooled results from 13 qualifying cohort and case-control studies, found that SSRIs were associated with a significantly increased risk of fractures. Introduction This study was conducted to assess whether people who take SSRIs are at an increased risk of fracture. Methods We conducted a meta-analysis of observational studies. Relevant studies published by February 2010 were identified through literature searches using MEDLINE (from 1966), EMBASE (from 1988), PsycINFO (from 1806), and manual searching of reference lists. Only cohort or case-control studies that examined the association of SSRIs and risk of fracture and bone loss were included. Data were abstracted independently by two investigators using a standardized protocol; disagreements were resolved by consensus. Random effects models were used for pooled analysis due to heterogeneity in the studies. Results Thirteen studies met inclusion criteria. Overall, SSRI use was associated with a significantly increased risk of fracture (relative risk, RR, 1.72; 95% CI [1.51, 1.95]; P < 0.001). An increased fracture risk associated with SSRIs also was observed in the three studies that adjusted for bone mineral density (RR, 1.70; 95% CI [1.28, 2.25]; P < 0.001) and in the four studies that adjusted for depression (RR 1.74; 95% CI [1.28, 2.36]; P < 0.001). SSRI use was not associated with bone loss in the two cohort studies of women (P = 0.29). The overall association between SSRI use and fracture risk was weaker (RR, 1.40; 95% CI [1.22, 1.61]), though still significant (P < 0.001) in analyses that accounted for apparent publication bias. Conclusions Use of SSRIs is associated with increased risk of fracture. The SSRIs may exert an increased risk of fracture independent of depression and bone mineral density.
引用
收藏
页码:365 / 375
页数:11
相关论文
共 50 条
  • [21] Use of selective serotonin reuptake inhibitors and risk of hip/femur fractures: A population-based case-control study
    Thio, B. M. K. S.
    de Vries, F.
    Egberts, T. C. G.
    Leufkens, H. G. M.
    van Staa, T. P.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S26 - S27
  • [22] Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations
    Myles, Nicholas
    Newall, Hannah
    Ward, Harvey
    Large, Matthew
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (11): : 1002 - 1012
  • [23] Can Selective Serotonin Reuptake Inhibitors Increase Cataract Risk? Results from a Case-Control Analysis
    Becker, Claudia
    Jick, Susan S.
    Meier, Christoph R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 422 - 423
  • [24] Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies
    Tie-Ning Zhang
    Shan-Yan Gao
    Zi-Qi Shen
    Da Li
    Cai-Xia Liu
    Hai-Chen Lv
    Yuan Zhang
    Ting-Ting Gong
    Xin Xu
    Chao Ji
    Qi-Jun Wu
    Scientific Reports, 7
  • [25] Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies
    Zhang, Tie-Ning
    Gao, Shan-Yan
    Shen, Zi-Qi
    Li, Da
    Liu, Cai-Xia
    Lv, Hai-Chen
    Zhang, Yuan
    Gong, Ting-Ting
    Xu, Xin
    Ji, Chao
    Wu, Qi-Jun
    SCIENTIFIC REPORTS, 2017, 7 : 1 - 9
  • [26] Selective Serotonin Reuptake Inhibitor Use and Increased Risk of Cataract Surgery: A Population-Based, Case-Control Study
    Erie, Jay C.
    Brue, Scott M.
    Chamberlain, Alanna M.
    Hodge, David O.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 158 (01) : 192 - 197
  • [27] Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis of Cohort and Case-Control Studies
    Yu, Shandong
    Chu, Yanpeng
    Li, Gang
    Ren, Lu
    Zhang, Qing
    Wu, Lin
    CIRCULATION, 2016, 134
  • [28] Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies
    Dagfinn Aune
    Abhijit Sen
    Lars J. Vatten
    Scientific Reports, 7
  • [29] Statins and the risk of colorectal cancer; a systematic review and meta-analysis of cohort and case-control studies
    Abbaszadeh, Mehrdad
    Bayrami, Fahimeh
    Zandifar, Samaneh
    Hemmati, Hamid Reza
    Valadkhani, Ali
    Peimanfar, Alireza
    IMMUNOPATHOLOGIA PERSA, 2025, 11 (01):
  • [30] Intake of Anthocyanins and Gastric Cancer Risk: A Comprehensive Meta-Analysis on Cohort and Case-Control Studies
    Yang, DeYi
    Wang, Xin
    Yuan, WeiJie
    Chen, ZiHua
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2019, 65 (01) : 72 - 81